According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -10,33ย โฌ. In 2022 the company made an earnings per share (EPS) of -11,14ย โฌ a decrease over its 2021 EPS that were of -9,44ย โฌ.